CVS Health (CVS) Q3 2026 Earnings
Adjusted EPS excludes $425 million amortization of intangible assets, a $193 million Omnicare guarantee charge, $13 million acquisition-related integration costs and $(3) million net realized capital gains, net of $(103) million tax impact. GAAP diluted EPS was $1.68.
How Did CVS Stock React to Q3 2026 Earnings?
Did CVS Beat Earnings? Q3 2026 Results
Yes. CVS Health reported Q3 2026 earnings of $2.09 a share on Nov 4, 2026, beating the $1.65 consensus estimate by 26.6%. Revenue was $108.4B against a $104.7B estimate.
CVS Health delivered a standout third quarter of 2026, posting adjusted EPS of $2.09 against a consensus estimate of $1.65, a beat of 26.61% that extended the company's streak of topping Wall Street's EPS forecasts to six consecutive quarters. Revenue climbed 5.4% year over year to $108.40 billion, clearing the $104.69 billion consensus by 3.54%, as all three operating segments contributed to consolidated adjusted operating income growth of 21.2% to $4.19 billion. The single largest driver was a sharp recovery in the Health Care Benefits segment, where Aetna's medical benefit ratio improved to 91.3% from 92.8% and adjusted operating income surged to $912 million from $314 million a year ago. GAAP diluted EPS came in at $1.68, a dramatic improvement from the prior-year period that was burdened by a multi-billion-dollar goodwill impairment. Looking ahead, management raised full-year 2026 adjusted EPS guidance to at least $8.20, up from a prior range of $7.90 to $8.10, and lifted its operating cash flow target to at least $15.50 billion, even as reports of a potential corporate breakup into two publicly traded companies added a broader strategic dimension to the quarter's results.
- Health Care Benefits adjusted operating income rose to $912 million from $314 million on improved underlying Government business performance
- Health Care Benefits MBR improved to 91.3% from 92.8%
- Government premiums up 8.2% to $28.1 billion
- Health Services revenue up 9.5% on pharmacy drug mix and brand inflation
- Health Services adjusted operating income up 2.7% on improved purchasing economics and drug mix
- Pharmacy & Consumer Wellness adjusted operating income up 10.6% on core pharmacy strength and Rite Aid asset acquisitions
- Prescriptions filled up 1.9% and pharmacy claims processed up 1.3% on a 30-day equivalent basis
- Prior years' health care cost estimates developed favorably by $1.3 billion year-to-date
- Absence of the prior-year $5.7 billion goodwill impairment drove the GAAP swing to profit
“Our colleagues build trust every day through delivering quality health care rooted in our purpose - to simplify health care one person, one family and one community at a time. Through their continued dedication, each of our businesses delivered another quarter of strong results.”
CVS Health CEO, on the earnings call
What Is CVS Health's Outlook?
CVS raised its full-year 2026 guidance: - Total revenues of at least $420.0 billion. - GAAP diluted EPS of at least $6.98, versus a prior range of $6.84 to $7.04. - Adjusted EPS of at least $8.20, versus $7.90 to $8.10. - Cash flow from operations of at least $15.5 billion, versus at least $11.5 billion. The guidance reconciliation projects: - Net income attributable to CVS Health of at least $9,002 million. - Adjusted income of at least $10,571 million. - Weighted average diluted shares of 1,289 million. - Excluded items of $1,730 million in intangible amortization, $26 million in net realized capital losses, $80 million in integration costs and the $193 million Omnicare guarantee, net of a $(460) million tax impact. The increases reflect stronger Health Care Benefits and Pharmacy & Consumer Wellness performance. Management is maintaining a cautious view for the rest of the year given continued elevated cost trends and potential macro headwinds.
CVS YoY Financials
| Metric | Q3 2026 | Q3 2025 | Year over year |
|---|---|---|---|
| Revenue | $108.4B | $102.9B | +5.4% |
| Operating Income | $3.6B | $1.1B | +211.2% |
| Net Income | $2.2B | $853.0M | +154.6% |
CVS Revenue by Segment
When Does CVS Health Report Next?
Figures from SEC filings and company reports. Not investment advice.